TARDBP and amyotrophic lateral sclerosis: As such, development of methods that can differentiate brain derived TDP-43 from other tissue sources are required to effectively use TDP-43 as a biomarker in behavioural-variant frontotemporal dementia and amyotrophic lateral sclerosis.28,29